Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial

Shashi N Kapadia,Benjamin J Eckhardt,Jared A Leff,Chunki Fong,Pedro Mateu-Gelabert,Kristen M Marks,Yesenia Aponte-Melendez,Bruce R Schackman

Drug and Alcohol Dependence Reports（2022）

引用 0|浏览9

暂无评分

摘要

•Hepatitis C treatment at a syringe service program cost $6035 per-enrolled participant.•The majority of the per-participant cost was for care coordination during treatment.•Estimated medicaid reimbursement was only $628 per enrolled participant.

查看译文

关键词

Hepatitis C,Substance use disorder,Harm reduction,Cost,Economic analysis,Care coordination

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要